rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0028833,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0205210,
umls-concept:C0206754,
umls-concept:C0521362,
umls-concept:C0684224,
umls-concept:C1280500,
umls-concept:C1696465,
umls-concept:C1707455
|
pubmed:issue |
3
|
pubmed:dateCreated |
1995-4-19
|
pubmed:abstractText |
To compare the effect of octreotide with f placebo on symptoms, tumour marker and quality of life in patients with gastrointestinal neuroendocrine tumours and liver metastases.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0954-6820
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
237
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
269-75
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7534331-Adaptation, Psychological,
pubmed-meshheading:7534331-Adult,
pubmed-meshheading:7534331-Aged,
pubmed-meshheading:7534331-Double-Blind Method,
pubmed-meshheading:7534331-Female,
pubmed-meshheading:7534331-Gastrointestinal Neoplasms,
pubmed-meshheading:7534331-Humans,
pubmed-meshheading:7534331-Hydroxyindoleacetic Acid,
pubmed-meshheading:7534331-Liver Neoplasms,
pubmed-meshheading:7534331-Male,
pubmed-meshheading:7534331-Middle Aged,
pubmed-meshheading:7534331-Neuroendocrine Tumors,
pubmed-meshheading:7534331-Octreotide,
pubmed-meshheading:7534331-Prospective Studies,
pubmed-meshheading:7534331-Quality of Life,
pubmed-meshheading:7534331-Questionnaires,
pubmed-meshheading:7534331-Tumor Markers, Biological
|
pubmed:year |
1995
|
pubmed:articleTitle |
Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours. Report on a double-blind, randomized trial.
|
pubmed:affiliation |
Medical Department A. Rikshospitalet, University of Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|